| Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway JE Hunter, AE Campbell, NL Hannaway, S Kerridge, S Luli, ... Biochemical Journal 479 (19), 2063-2086, 2022 | 9 | 2022 |
| HCV activates somatic L1 retrotransposition—a potential hepatocarcinogenesis pathway PD Sudhindar, D Wainwright, S Saha, R Howarth, M McCain, Y Bury, ... Cancers 13 (20), 5079, 2021 | 8 | 2021 |
| Renal Ciliopathies: Promising drug targets and prospects for clinical trials L Devlin, P Dhondurao Sudhindar, JA Sayer Expert Opinion on Therapeutic Targets 27 (4-5), 325-346, 2023 | 6 | 2023 |
| Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation B Zadran, PD Sudhindar, D Wainwright, Y Bury, S Luli, R Howarth, ... British Journal of Cancer 128 (7), 1236-1248, 2023 | 5 | 2023 |
| Factors involved in the regulation of Long Interspersed-Nuclear-Elements (L1) retrotransposons in the context of Hepatocellular Carcinoma P Dhondurao-Sudhindar Newcastle University, 2022 | 1 | 2022 |
| Hepatitis C virus infection, endogenous retrotransposons activation and cancer risk R Shukla, HL Reeves, S McPherson, M McCain, P Sudhindar, Y Bury, ... Journal of Hepatology, 2020 | | 2020 |
